Our Leadership

Co-Founder
Dr. Kirsch earned his medical degree from SUNY Health Science Center in New York, where he received two NIH Research Fellowship Awards and was inducted into Sigma Xi Research Society. In 2006, he was honored by his medical school as the Master Teacher in Urology. He completed both a residency in general surgery and urology at the Columbia University College of Physicians & Surgeons in New York. He then completed his fellowship in pediatric urology at the Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, where he was an American Foundation for Urological Diseases Scholar. Dr. Kirsch is a past secretary and president of the Society for Fetal Urology and is a member of the American Urological Association (AUA), American Association of Pediatric Urologists (AAPU), American Academy of Pediatrics (AAP), and Society of Pediatric Urology (SPU). He is Chairman of the AAP, Section of Urology. He has written extensively in the field of pediatric urology, with emphasis on vesicoureteral reflux, cryptorchidism, and magnetic resonance urography, publishing nearly 300 journal articles and book chapters. Dr. Kirsch has invented several devices and developed an endoscopic technique to correct urinary reflux in children that has become the standard of care for children worldwide. He has personally trained over 1000 physicians on the procedure, and has lectured throughout North America, South America, Asia, and Europe.
Dr. Kirsch is active in robotic reconstructive surgery and serves as a national proctor for Intuitive Surgical. He has served on the advisory committee to the ABU and was sub-specialty editor of the Journal of Urology. He is on the AAP Pediatric Medical Device Advisory Committee. Currently, Dr. Kirsch is professor and chief of pediatric urology at Emory University School of Medicine and a partner at Georgia Urology, where he serves as the medical director. He is on staff at Children's Healthcare of Atlanta where he serves Chief of Urology at Scottish Rite and Medical Director of Pediatric Robotic Surgery, Medical Director of Urology, Clinical Operations Committee, Clinical Research Oversight Committee, and System Peer Review Subcommittee.

Co-Founder
Dr. Barroso graduated from Bahian School of Medicine in Salvador, Brazil (1992). He completed his residency program in general surgery (in Salvador) and in Urology (in Sao Paulo) at the Uronephrology Institute of São José do Rio Preto. He completed a research fellowship in pediatric urology at Children’s Hospital of Michigan at Wayne State University (1996). Dr. Barroso earned his PhD in urology at the Federal University of Sao Paulo in 2000. He returned to Salvador where he was Associate Professor of Urology at the Bahian School of Medicine (2005). He rose to Professor of Urology at the Federal University of Bahia (FUB, 2010), where he is Chairman of Urology at FUB and Head of the Nephrourology at University Hospital.
Dr. Barroso is the current President of the Brazilian Society of Urology (BSU, Bahian section), member of the board, and corresponding member of the Society of Pediatric Urology, an international member of the American Urological Association, member of the Ibero-American Society of Urology, the International Children’s Continence Society, and the International Neurourology Society. He is a member of the Bahian Academy of Medicine and the Bahian Academy of Science. He has served as Chief of Pediatric Urology of the BSU (2006, 2014). Dr. Barroso is Head of one of three fellowship programs of the BSU, where many fellows have gone on to serve as pediatric urologists all over Brazil. Dr. Barroso is Professor in the PhD program at the Bahian School of Medicine, supervising urologists and physiotherapists. He coordinates a multidisciplinary center for the treatment of neurogenic and non-neurogenic voiding dysfunction and is the head of reconstructive surgery for children and adults at the Federal University of Bahia Hospital.
Dr. Barroso published more than 150 manuscripts and books chapters, including innovative surgical techniques and new treatments for diurnal and nocturnal urinary incontinence in children. He holds a grant from the Brazilian National Council for Scientific and Technological Development and several patents for urological inventions in Brazil, USA and Europe. Dr. Barroso has lectured extensively in Brazil and around the world, receiving research awards in Japan, USA, Italy and Brazil.

Leverages UPS operations experience to optimize efficiency at Global Continence. Oversees supply chain, organizational planning, and process scalability, ensuring seamless coordination across teams and partners. His hands-on leadership drives execution and keeps the company on track for key milestones.

Dr. Emily Blum is the Medical Director of the Global Center for Medical Innovation (GCMI), an affiliate of Georgia Institution of Technology. GCMI serves to accelerate the development, testing, training and commercialization of innovative medical products. In her role she serves to bring in new programs and innovative ideas from local physician entrepreneurs while serving as an internal knowledge resource for program development teams guiding the clinical needs discussion around product innovation. She has lectured across the country on fostering an innovative mindset in medicine and has served on the advisory board of the Medtech Women@SEMDA/Southeast life Sciences. In her role to champion commercialization of medical devices she has served as a reviewer/judge for numerous medical innovations pitch rounds. Additionally, Dr. Blum is an Adjunct Assistant Professor at Emory University School of Medicine in the Department of Urology and practices with pediatric urology Georgia Urology, PA. She is board-certified in adult and pediatric urology.
Dr. Blum graduated cum laude from Bowdoin College with special honors in Biology and was elected to Phi Beta Kappa. She received her medical doctorate from Boston University where she graduated cum laude and was elected to Alpha Omega Alpha. She completed her general surgery internship and urologic residency at William Beaumont Hospital in Royal Oak Michigan. Dr. Blum continued her training as the A. Barry Belman Pediatric Urology Fellow at Children’s National Medical Center in Washington, D.C. During the research year of the 2-year fellowship program, she was also awarded the Joseph E Robert (JER), Jr. Fellowship for Pediatric Surgical Innovations. Dr. Blum’s research projects focused on utilizing artificial intelligence to assist in analyzing radiographic studies. She won top honors at the JER Academic Symposium both years.

Our Advisors

Scientific Advisor
Dr. Austin is the Chief of Urology, The Edmond T. Gonzales, Jr., MD, Endowed Chair in Pediatric Urology and the Director of the Pediatric Urological Basic Science Program at Texas Children’s Hospital and Professor of Urology at Baylor College of Medicine in Houston, Texas. Dr. Austin leads a robust basic science research program that is funded by the NIH and investigates the molecular pathways involved with renal and bladder injury resulting from obstructive uropathy. In addition to his basic science work, Dr. Austin is also recognized as a leading clinical trial investigator of lower urinary tract function and serves on global advisory panels for national and international urology clinical trials. Dr. Austin is the President of the American Association of Pediatric Urology, Secretary/Treasurer-elect for the Society of Pediatric Urology and the former General Secretary for the International Children’s Continence Society. Dr. Austin has served on the Executive Committees for the Society of Pediatric Urology, American Association of Pediatric Urology, Section on Urology of the American Academy of Pediatrics and the International Children’s Continence Society. He was the recipient of the John W. Duckett Pediatric Research Excellence Award in 2016 from the American Urology Association’s Urology Care Foundation that is presented annually to a U.S. physician, scientist or researcher for exceptional pediatric research and for advancing treatment and improving the quality of life for children with urologic conditions. Dr. Austin has published over 106 peer-reviewed articles and authored/edited 29 books and book chapters.

Scientific Advisor
Dr Piet Hoebeke is urologist in the Department of Urology at the University Hospital, Gent, Belgium, and is Senior Full Professor of Pediatric Urology. Since January 2016 he has been the Dean of the Faculty of Medicine and Health Sciences at Ghent University.
He received his initial medical training at the University of Gent, and then trained as a paediatric urologist at Utrecht University, the Netherlands. Dr Hoebeke’ s special fields of interest are incontinence in children and urogenital reconstruction in children, adolescents and adults. He is a member of three multi-disciplinary teams – paediatric urology and nephrology; disorders of sex development and gender dysphoria at Ghent University Hospital. He is involved in pediatric urology surgery in general and urogenital reconstruction in children and adolescents and in female to male transsexual surgery. He is board member and treasurer of the European Society of Pediatric Urology (ESPU). He is Fellow of the European Board of Urology (FEBU) and Fellow of the European Academy for Pediatric Urology (FEAPU).
Dr Hoebeke has presented many papers at national and international meetings and has authored and co-authored more than 220 publications in peer-reviewed journals and 30 book chapters. He is editor of the Journal of Pediatric Urology.

Scientific Advisor
Dr. Cristian Sager graduated from the Faculty of Medical Sciences, National University of Rosario, Argentina in 1998. From 1992 to 1999 he served as Assistant to the Chair of Histology and Embryology. He completed his residency and Head of Residency in Urology at Hospital Universitario Centenario de Rosario, Argentina in 2003. In 2001 he served an internship in Urology at Fundación Puigvert, Barcelona, Spain.
He began his career in Pediatric Urology attending the Victor J Vilela Children's Hospital in Rosario, Argentina from 2000 to 2003. Dr. Sager completed his training as a Pediatric Urologist at Prof. Dr. JP Garrahan Pediatric Hospital in Buenos Aires Argentina (2004-2006) where he received his career development and training in the Urodynamic and Bladder Dysfunctions Unit. Dr Sager was awarded a Basic Urology Research Grant and Best Research Paper Award in 2006.
He is a member of the spina bifida and Transition in Urology interdisciplinary team. He was Coordinator of the Pediatric Urology Group of the Argentine Society of Urology from 2018 to 2020. Additionally He has developed and organized five editions of the National Pediatric Urology Conference at Garrahan Hospital.
Dr. Sager has published paper and articles in national and international journals. He actively participates in the Argentine Society of Urology, the Argentine Society of Pediatrics, the Ibero-American Society of Pediatric Urology and CAU.
He is currently completing his training in statistics and clinical effectiveness at the University of Buenos Aires, Argentina.

Financial Advisor
Mr. Katz is the President and Chief Investment Officer of Matrix Asset Advisor, a New Yok Based Investment Management firm that he founded in 1986. He has overall responsibility for the firm’s investment efforts and serves on the Boards of two publicly traded mutual funds (Matrix Advisors Value Fund and the Matrix Advisors Dividend Fund)
He graduated summa cum laude from Union College with a Bachelor of Arts degree in Economics. He received a Master of Business Administration degree, with a concentration in Finance, from New York University Graduate School of Business in 1987, graduating with distinction. Mr. Katz is a CFA charterholder.
After initially working at Management Asset Corporation (Westport, CT), Mr. Katz co-founded Value Matrix Management with the late John M. Gates in 1986. He served as the firm’s Senior Vice President and Chief Investment Officer and was Head of the Investment Policy Committee. In 1990, he merged Value Matrix Management organization into Matrix Asset Advisors. Mr. Katz chairs the Investment Policy Committee and is a Portfolio Manager/Analyst.
He appears frequently as a guest on CNBC and Bloomberg Radio.

Scientific Advisor
Dr. Bujons is a Pediatric Urologic Surgeon specializing in the treatment of bladder exstrophy, spina bifida, sexual development anomalies (DSD) and pediatric lithiasis through minimally invasive surgery techniques such as laparoscopy, robotics and endourology with flexible instruments and lasers.
She obtained her degree in Medicine and Surgery from the University of Barcelona (UB) and then completed her Urology Residency at Fundació Puigvert. She has a PhD in Sexuality in Spina Bifida from the Autonomous University of Barcelona (UAB) and an Executive Master in Healthcare Organizations Leadership (EMDOS) from Esade. In 2008 she joined the Urology Department of Fundació Puigvert where she currently holds the position of Head of the Division of Pediatric Urology.
Dr. Bujons has authored numerous scientific papers, book chapters and several videos on surgical techniques. She has more than 200 papers presented in conferences and scientific meetings, some of them awarded, participating as well as guest lecturer in many of them. She has also been involved in the organization of several courses, congresses and scientific meetings and has worked in many research works throughout his career.
She is Associate Professor at the Faculty of Medicine of the Autonomous University of Barcelona (UAB) and is Professor of the Master in Pediatric Urology at the International University of Andalusia (UNIA).
Dr. Bujons is Fellow of the European Academy of Pediatric Urology (FEAPU), Vice President of the Sociedad Iberoamericana de Urología Pediátrica (SIUP), member of the Educational Committee of the European Society of Pediatric Urology (ESPU), associate member of the EAU Section of Uro-Technology (ESUT), Board Member of the EAU Working Group on Paediatric Urology (EWPU), Ex-Officio EWPU Board Member of the EAU Section of Urolithiasis (EULIS) and serves as reviewer for the Britihs Journal of Urology, the Journal of Pediatric Urology, Actas Españolas de Urología and Archivos Españoles de Urología.

Scientific Advisor
Dr. Yoshiyuki Ohtomo, a prominent figure in the fields of Pediatric Nephrology and Continence, has dedicated his life to advancing pediatric medicine. Born in Japan, he began his medical journey at Juntendo University School of Medicine in Tokyo, where his passion for medicine took root. Dr. Ohtomo's academic pursuits led him to attain a PhD in Pediatric Nephrology at Juntendo University Graduate School of Medicine. He further honed his expertise during his doctoral research at Sweden's Karolinska Institute, specializing in Developmental Renal Physiology under the mentorship of Prof. Anita Aperia.
Over several decades, Dr. Ohtomo has held pivotal roles at esteemed institutions in Japan, starting as a Resident at Juntendo University Hospital in Tokyo. He later became an Assistant Professor in Pediatric Nephrology, progressing to the role of Associate Professor at Juntendo University Urayasu Hospital in Chiba, Japan. Subsequently, he served as Chief of the Division of Nephrology at Saitama Children’s Medical Center in Saitama, Japan. Presently, he serves as a Professor at Juntendo University Nerima Hospital in Tokyo, where his expertise continues to shape the landscape of pediatric medicine.
Dr. Ohtomo actively participates in several medical associations, including the Japan Pediatric Society and the Japanese Society of Pediatric Nephrology. He represents the medical community and contributes to the growth of knowledge in these domains. Dr. Ohtomo's significant leadership role as the President of the Japanese Society on Enuresis and Incontinence underscores his commitment to improving the quality of life for children facing these challenges.
Furthermore, Dr. Ohtomo's global influence is evident through his membership in the International Pediatric Nephrology Association and his role as a Board Member of the International Children’s Continence Society. In these capacities, he collaborates with peers from around the world to shape the future of pediatric nephrology and continence care.
Dr. Yoshiyuki Ohtomo, with his exceptional academic background and tireless dedication to the field, serves as an invaluable scientific advisor to Global Continence. His contributions to pediatric medicine and his leadership in the realms of nephrology and continence make him a respected figure, both in Japan and on the global stage. His work continues to inspire future generations of medical professionals and offers hope to countless children and families affected by these conditions.

Scientific Advisor
Dr. Copp is Professor and Chief of Pediatric Urology at the University of California at San Francisco (UCSF) and has been on faculty at UCSF since 2009. Dr. Copp earned her medical degree at Pennsylvania State University College of Medicine. She completed a urology residency at the University of Virginia and a pediatric urology fellowship at Stanford University, where she also earned a masters degree in epidemiology.
Dr. Copp is the UCSF Pediatric Urology Fellowship Director and the director of urologic care for children with Spina Bifida. She is the Co-Director of the UCSF Lifetime Congenital Urology Program, a joint effort between Pediatric and Adult Urology to understand and care for adults with congenital urologic conditions that will require long-term urologic care. Dr. Copp’s research interests include understanding the results of health care practice and intervention, specifically among children with UTI and examining and improving the clinical and quality of life outcomes of individuals with urologic congenitalism.
Dr. Copp has been an active member of the Pediatric Urology Community. She currently serves as the Secretary/Treasurer for the Societies for Pediatric Urology. She was the President and the Secretary/Treasurer for the Society for Fetal Urology. Dr. Copp created the Pediatric Urology Fellowship Lectures Online (PedsUroFLO) series delivered by pediatric urology faculty from across the United States and abroad. She recently received an American Urological Association Presidential Citation for service, leadership, and education in pediatric urology. In addition, Dr. Copp has devoted time to educating patients and families about pediatric urologic conditions as a member of the Urology Care Foundation’s Public Education Council and Pediatric Health Committee.

Scientific Advisor
Professor CK Yeung is a renowned leader in pediatric urology and surgery, holding the position of Presidential Chair Professor and Chair Chief of Pediatric Surgery & Pediatric Urology at the Chinese University of Hong Kong (Shenzhen). His groundbreaking work in minimally invasive surgery and robotics has transformed pediatric surgical care, and his development of novel techniques like pneumovesicoscopic bladder reconstruction has paved the way for cutting-edge treatments. Professor Yeung has also led large-scale studies on Helicobacter pylori infection and primary nocturnal enuresis (bed-wetting) in children, reshaping our understanding of these conditions and their management.
A past president of the International Children Continence Society (ICCS), Professor Yeung has made significant contributions to the field of pediatric continence care, particularly in the study and treatment of lower urinary tract dysfunctions. He has authored over 180 peer-reviewed scientific articles, including groundbreaking work on bed-wetting published in prestigious journals like The New England Journal of Medicine. His research has greatly influenced the clinical approach to bed-wetting, making him a global authority on the subject.
As an advisor for Global Continence and the Soluu® product, Professor Yeung brings
unmatched expertise in pediatric continence care. His research and leadership in treating enuresis directly align with the goals of Soluu®, a device that uses advanced neuromodulation to address bed-wetting in children. His clinical insight and experience with innovative technologies make him an invaluable asset in guiding the development and clinical application of Soluu®, ensuring its success in transforming the treatment of bed-wetting.

Scientific Advisor
Dr. Tiago Rosito is Professor and Chairman of Urology at Universidade Federal do Rio Grande do Sul, the largest academic unit in south Brazil and one of the largest in South America. He earned his medical degree from Universidade Federal do Rio Grande do Sul Medical School in Porto Alegre, Brazil. He completed both residency in general surgery and Urology at Hospital de Clínicas de Porto Alegre. He then completed his fellowship and PhD in Pediatric Urology at Hospital São Paulo in São Paulo, Brazil. Returning to Porto Alegre he completed a new fellowship in reconstructive urology and a master's degree in surgical science. Since then, he is the Director of Pediatric and Reconstructive Urology at Hospital de Clínicas de Porto Alegre.
Dr. Rosito is the first Secretary of the Brazilian School of Pediatric Urology, treasurer of Iberoamerican Society of Pediatric Urology, and Chief of Pediatric Urology Section of Brazilian Society of Pediatric Urology. Dr Rosito is member of most of the Pediatric Urology Societies internationally. He has published more than 50 journal articles and book chapters in the field. Dr. Rosito was an invited surgeon and Professor in many international congresses and Hospitals in Latin America.

Scientific Advisor
Dr. Serdar Tekgül is Professor of Urology at Hacettepe University in Ankara, Turkey, where he leads the Section of Pediatric Urology—one of Europe's accredited training centers. After completing his pediatric urology fellowship at the University of Washington, he dedicated his career entirely to pediatric urology. His clinical and academic focus includes obstructive uropathy, reflux, voiding dysfunction, urolithiasis, bladder reconstruction, and especially the management of nocturnal enuresis.
As a global leader in pediatric urology, Dr. Tekgül brings extensive clinical expertise, academic insight, and international perspective to Global Continence and the Soluu™ project. His involvement will help guide clinical strategy, support evidence-based development, and expand the global reach of Soluu™ as a groundbreaking solution for bedwetting. With over 80 peer-reviewed publications and key roles in shaping international guidelines and education, Dr. Tekgül will be instrumental in advancing Soluu’s impact on children worldwide.

Scientific Advisor
Ananda Nacif B. Nunes is a Brazilian Physiotherapist and Urotherapist. She leads the urotherapy clinic and clinical urology tests at the Pediatric Urology Department at Sidra Medicine (Doha, Qatar), assisting patients and families in the treatment and management of bladder and bowel dysfunctions. She is a member of the multidisciplinary team for spina bifida. Academically involved as a non-physician faculty member in the Pediatric Urology Fellowship Program at Sidra Medicine (ACGME-I).
She holds a Master’s degree in Medicine and Human Health (2020, Brazil) and completed postgraduate/academic specialization in pediatric and adult pelvic floor physiotherapy (2019, Brazil). Active board member of the European Society for Pediatric Urology - Nurse (ESPU-N).
She is a licensed physiotherapist in Brazil (2017), Qatar (2021), and the United Kingdom (2023).

Scientific Advisor
Dr. Pope is Professor of Urology and Pediatrics and Chief of Pediatric Urology at the Monroe Carell, Jr. Children’s Hospital at Vanderbilt, in Nashville, TN. He also serves as the program’s fellowship director, overseeing the education of future leaders in the field. He has been on the faculty at Vanderbilt University Medical Center for over 20 years.
In addition to his daily clinical responsibilities, Dr. Pope has had multiple leadership positions with the Societies of Pediatric Urology and the American academy of Pediatrics, Section on Urology, has been a section editor for the Journal of Urology, and is a prolific speaker at local, national, and international levels. Dr. Pope has traveled to Guatemala for many years providing care to an underserved international community. He has over 130 published journal articles, over 350 research presentations at local and national meetings and has written over 20 book chapters on pediatric urology subjects. He has always been involved in research to advance the field of pediatric urology. His research has been widely published and ranges from basic science study of the kidney and bladder to implementing new treatments for bowel and bladder incontinence in children. He has held grants from the National Institute of Health, the National Kidney Foundation, and the American Urologic Foundation, among others.
Dr. Pope received his bachelor’s degree from Wake Forest University magna cum laude and graduated from the University of Tennessee College of Medicine with highest honors. He completed his general urology training at Vanderbilt University Medical Center, where he won awards for his research. He then continued his clinical and academic training with two-year pediatric urology fellowship at Riley Children’s Hospital (Indiana University) in Indianapolis, again winning several awards for his advancement of urological science.

Scientific Advisor
Dr. José Murillo B. Netto did his initial medical training at the Faculdade de Medicina de Barbacena (FAME-FUJOB), in Barbacena, Minas Gerais, Brazil, where he graduated in December 1992. He then completed his residence training in Urology at the Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (HCFMRP-USP), Ribeirão Preto, São Paulo, Brazil, and was an Observer Fellow at the Children’s Hospital of Alabama, at Birmingham, AL, USA (1998-1999). In 2001, Dr. Netto earned his PhD in Surgery/Urology at the Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP). During the years of 2018-2019, Dr. Netto work as a Visiting Professor at the Department of Urology of School of Medicine of Yale University, doing mostly research in bladder function and incontinence in children.
Dr. José Murillo B. Netto is a Full Professor at the Department of Surgery, Division of Urology, at the Universidade Federal de Juiz de Fora (UFJF), Juiz de Fora, Minas Gerais, Brazil, since 2004 and is the Chief of Pediatric Urology at the University Hospital of the Universidade Federal de Juiz de Fora (HU-UFJF). He is also an Associate Professor of Surgery at the Faculdade de Ciências Médicas e da Saúde de Juiz de Fora (SUPREMA). At the Universidade Federal de Juiz de Fora, Dr. Netto is also a Professor in the PhD program (Programa de Pós-Graduação em Saúde – PPGS) and the coordinator of the Interdisciplinary Group of Research in Urology (NIPU), where he supervises physicians, physiotherapists, psychologists and nurses in their Master and PhD studies and theses. He is the head of the Lower Urinary Tract Dysfunction, Neurogenic Bladder and Enuresis Clinics, coordinating a multi professional team consisting of physicians, physiotherapists, psychologists and nurses, as well as, post-graduating and graduating students.
Dr. Netto is a former Chief of the Department of Pediatric Urology of the Sociedade Brasileira de Urologia (SBU) e is the current Chief of the Department of Pediatric Urology at the Section of Minas Gerais of the Sociedade Brasileira de Urologia (SBU). He is a corresponding member of the American Urological Association (AUA), a member of the International Children’s Continence Society (ICCS), of the Sociedad Iberoamericana de Urologia Pediatrica (SIUP).
Dr. Netto has published about a 100 studies and book chapters in pediatric urology, being most of them related to enuresis and lower urinary tract symptoms. He holds a grant from the Brazilian National Council for Scientific and Technological Development (CNPQ) and has received other grants from the Fundação de Apoio a Pesquisa do Estado de Minas Gerais (FAPEMIG), and from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).
Dr. José Murillo B. Netto has lectured extensively in Brazil and around the world, receiving research awards in Japan, USA, Spain and Brazil.

Scientific Advisor
Dr. Göran Läckgren is a Professor of Pediatric Urology at the University Children´s Hospital, Uppsala, Sweden. He graduated from the University of Uppsala where he had his training as a pediatric surgeon and urologist. He became the head of the section of Pediatric Urology in 1986. He was one of the founders of the Swedish Enuresis Academy (SEA) and was the President from 1993 until 2008 and is still an active member of the Board. He has been the main organizer of the first congress of ICCS (International Children’s Continence Society) in
1997 in Paris and main organizer of the Second joint Congress of AAP and ESPU in 2005 in Uppsala.
Dr Läckgren has been a member of the board of the European Society for Pediatric Urology and has acted as Treasurer and later as the President of the society. He was appointed Honorary Member of the ESPU in 2015. Dr Läckgren is a member of the Society for Pediatric Urology Surgeons (SPUS) an international member of the American Association of Genito Urinary Surgeons (AAGUS). Dr Läckgren was appointed the first Professor of Pediatric Urology at the University of Uppsala in 2005. His main scientific interest has been on the function of the undescended testis; Vesicoureteral Reflux-particularly endoscopic treatment; Enuresis and urinary incontinence; Dr Läckgren published over 130 articles and book-chapters in Pediatric Urology. He has been a visiting professor and lecturer to more than 40 countries all over the world particularly on the topics of Endoscopic treatment of Vesicoureteral Reflux and on Nocturnal Enuresis.

Scientific Advisor
Tryggve Nevéus is a senior consultant in Pediatric Nephrology at Uppsala University Children’s Hospital as well as a Professor of Pediatrics and Excellent Teacher at Uppsala University, Sweden.
He has been Secretary General and President of the International Children’s Continence Society 2006-2012 and 2014-2022, respectively, and is the current President of the Swedish Enuresis Academy
Prof Nevéus’ main field of research has been nocturnal enuresis and pediatric uro-nephrology in general. He has published 100 scientific manuscripts, books, and book chapters.

Scientific Advisor
Dr. Cooper is Professor and Vice Chairman of Urology at the University of Iowa, Iowa City. He also serves as Director of the Pediatric Urology Division at the Children’s Hospital. In addition, he serves as Senior Associate Dean for Medical Education in the University of Iowa Carver College of Medicine. In 2017 he was awarded the endowed Tyrone D. Artz Chair in Urology.
Dr Cooper is the Executive Secretary of the Pediatric Urology Advisory Council to the American Board of Urology, past-president of the American Academy of Pediatrics Affiliate Section on Urology, past-president of the Society for Fetal Urology and of the North Central Section of the American Urologic Association, and an active member of the American Association of Genitourinary Surgeons. He serves on the editorial board of the Journal of Pediatric Urology and has over 175 urologic publications.
Dr Cooper graduated from the University of Iowa College of medicine where he was awarded the Nathan G. Alcock Scholarship for Outstanding Achievement in Urology. He completed his Urology residency after receiving an Outstanding Teaching Award from medical students and the Iowa Urologic Society and has received multiple teaching awards including a Collegiate Teaching Award. He is the recipient of the 2015 Distinguished Alumni Award for Achievement from the University of Iowa Carver College of Medicine.
Dr Cooper completed a two-year pediatric urology fellowship at the Children’s Hospital of Philadelphia, Pennsylvania, where he was the recipient of an American Foundation for Urologic Disease and American Urologic Association Research Scholarship. Additionally, he was awarded the first Frank Hinman, Jr. Award for clinical research by the Society of Pediatric Urology.

Scientific Advisor
Dr. Van Batavia is an Assistant Professor in the Division of Urology (Department of Surgery) at the University of Pennsylvania and the Children’s Hospital of Philadelphia. As a surgeon-scientist, Dr. Van Batavia spends half of his time performing basic science and translational research in neuro-urology and medical device development. He is currently using state-of-the-art neuroscience techniques to decipher the brain-bladder neural pathways involved in volitional voiding and his work is supported by an NIH/NIDDK K08 grant. He recently received the 2019 Urology Care Foundation Rising Star in Urology Research Award and 2018 Diokno-Lapides Essay Contest Grand Prize.
Over the past 4 years, his research has been funded by grants from CHOP, the NIH, and the FDA (through the Philadelphia Pediatric Medical Device Consortium). He is also a co-inventor on a provisional patent for a urological device which was developed through the BioStrategy Partners-Amp Tech Germinator Program. He has published over 50 peer-reviewed articles and authored 10 book chapters on urologic topics.
Dr. Van Batavia holds several leadership roles. He is currently the Co-Chair of the Membership Committee of the American Academy of Pediatrics (AAP) Section on Urology (SOU) and co-editor of the section’s biannual newsletter. He formerly served as the Fellow representative to the AAP SOU and Pediatric Urology Coordinating Council, and as a member of the Pediatric Urology Advisory Council to the American Board of Urology.
Dr. Van Batavia received his bachelor’s degree in molecular biophysics and biochemistry from Yale University and his Doctor of Medicine from Columbia University in New York City. He completed his general surgery internship and urology residency at Colombia University Medical Center/New York - Presbyterian Hospital and received the Mitchell C. Benson Resident Research Award at graduation in 2015. He completed his fellowship in pediatric urology at the Children’s Hospital of Philadelphia and was supported by a Urology Care Foundation (UCF) Research Scholar Award and received the 2017 Outstanding Graduate Scholar Award from the UCF. Dr. Van Batavia is currently completing his Master of Science in Translational Research from the University of Pennsylvania and has taken Medical Device and Healthcare Entrepreneurial classes at the Wharton School.

Scientific Advisor
Dr. Susan Kirsch granulated from Union College and completed medical school at Downstate Medical College in Brooklyn, New York. She completed an internship in Medicine at Cornell’s New York Hospital in New York City and completed her residency in Psychiatry at Emory University School of Medicine in Atlanta. She then completed a fellowship in Child and Adolescent Psychiatry at Emory. Dr. Kirsch is a Board-Certified Child, Adolescent, and Adult Psychiatrist. She is a member of the American Academy of Psychiatry, American Academy of Child and Adolescent Psychiatry, and the Georgia Psychiatric Physicians Association. She is clinical assistant professor at Emory University School of Medicine. Dr. Kirsch practices in Atlanta, GA

Scientific Advisor
Dr. Renea Sturm is an Assistant Professor of Pediatric Urology at University of California, Los Angeles (UCLA). She is a physician-scientist leading bench to bedside research in surgical innovation, including multi-disciplinary collaborative work that applies novel biomaterials to tissue engineering and reconstructive surgery. The primary aim of her research is to apply basic science and technological advancements to improve equity, quality, and consistency in urologic surgery regardless of surgeon experience or care setting. Dr. Sturm was recently recognized as a 2022 Outstanding Graduate Scholar by the American Urological Association/Urology Care Foundation (AUA/UCF) for her 2-year project that developed highly elastic biomaterials for urinary tract applications. Her research is supported by grants from the National Science Foundation, the Technology Development Group at UCLA, the UCLA Clinical and Translational Sciences Institute, and the AUA/UCF. Dr. Sturm’s clinical practice includes pediatric reconstructive minimally invasive and endoscopic surgery, complex hypospadias repair, and lower urinary tract conditions including nocturnal enuresis.

Clinical Research Advisor
Dr. Barajas is a healthcare professional with over 15 years of experience in Clinical Research in Latin-American, Europe, and US. Since June 2021 she was appointed as Regional Operations Head for LATAM in Merck & Co., ensuring the oversight of the clinical trials along the region as well as being the POC for to the rest of the functional areas both Globally and within LATAM.
Before her current role she was the Clinical Research Director for Mexico MSD running more than 60 clinical trials in different therapeutic areas with focus on oncology, infectious diseases, primary care, and vaccines.
Through her career she has had the opportunity to work in different pharmaceutical companies with specialized responsibilities and involved in global projects such as Study Budget Center of Excellence, Risk Based Monitoring, Monitoring Excellence, Neoadjuvant Clinical Trials, and electronic Trial Master File (eTMF).
She holds a Master’s in Science with focus in clinical research, as well as a certification as a Black Belt Lean Six Sigma, which have supported and enhanced her career and thus implementing continuous improvement for the standard operating procedures such as cycle times, training, and eTMF.

Scientific Advisor
Marie-Klaire Farrugia MD MD(Res) FRCSEd(Paed.Surg) is a Consultant Paediatric Urologist, and Clinical Lead for Paediatric Surgery, in Chelsea & Westminster and Imperial College Hospitals, London, UK. She completed her pediatric surgery training in leading hospitals including Great Ormond Street Hospital, Kings College Hospital, St George’s Hospital and the Oxford Radcliffe, obtaining the fellowship in Paediatric Surgery at the Royal College of Surgeons of Edinburgh in 2008. She undertook two years of basic science research at the Institute of Child Health/ Great Ormond Street, whereby she investigated the effect of in-utero urinary tract obstruction on bladder urodynamics and on the developing kidneys – her thesis was awarded a research MD by the University of London. She went on to sub-specialise in Paediatric Urology, completing her fellowship in 2010. Miss Farrugia was awarded the joint American Academy of Pediatrics and European Society for Pediatric Urology travelling fellowship the same year, for her clinical research work on management of the congenital megaureter. Miss Farrugia became an attending Pediatric Urology Consultant in Chelsea & Westminster Hospital in 2011; an honorary Senior Clinical Lecturer at Imperial College London in 2018; and has been the clinical lead for Paediatric Surgery across the West London Children’s Healthcare Alliance since 2019. She has been awarded three clinical excellence awards by the UK National Health Service (NHS). She has published numerous invited reviews, consensus statements, book chapters and educational modules on a congenital urinary tract conditions including fetal intervention for lower urinary tract obstruction, obstructive megaureter, vesicoureteric reflux and pelvi-ureteric junction obstruction. She is the European international member on the Society of Fetal Urology. Outside work, she is likely to be found in a CrossFit Box.

Scientific Advisor
Dr. Jonathan C. Routh is a pediatric urologist and health services researcher at Duke University School of Medicine, where he serves as the Chief of Children’s Surgery and the Paul H. Sherman Distinguished Associate Professor (with Tenure) of Urology, Pediatrics, and Population Health Sciences. He attended the University of North Carolina School of Medicine then completed his urologic residency at the Mayo Clinic in Rochester, Minnesota and dual fellowships in Pediatric Urology and Pediatric Health Services Research at Boston Children’s Hospital. He obtained a Master's of Public Health degree from the Harvard School of Public Health.
Dr. Routh’s clinical interests include minimally-invasive surgery, neurogenic and non-neurogenic voiding dysfunction, complex urologic reconstruction (particularly in children with spina bifida), surgical and non-surgical management of children with disorders of sex development, and pediatric urologic oncology (particularly Wilms tumor and rhabdomyosarcoma).
Dr. Routh’s research is funded by awards from the NIH, CDC, FDA, and multiple foundations and industry partners. He is the Chair of the Steering Committee for the CDC-funded Urologic Management Protocol to Preserve Initial Renal Function (UMPIRE) study for children with spina bifida. He has authored more than 175 peer-reviewed research articles and 13 book chapters in addition to more than 250 research presentations at regional, national, and international conferences.

Financial Advisor
Per Langoe is a highly regarded financial advisor at Global Continence Inc., known for his extensive international experience and deep commercial expertise. His career in the healthcare and pharmaceutical industries is highlighted by significant roles at Pharmacia Corporation, Q-Med, Galderma, and Nestlé Skin Health. During his time at Palette Life Sciences, which he helped establish, Per was dedicated to developing products aimed at enhancing the quality of life on a global scale.
While at Palette Life Sciences, Per’s role involved the strategic oversight of operations and resources, ensuring the company’s goals were met. He was instrumental in bridging communication between the board of directors and the management team, crucially influencing the company’s strategic decisions.
In his current position at Global Continence Inc., Per’s contributions as an advisor have been invaluable. His expertise and advice have greatly supported the company’s growth and advancement towards commercialization.
Educationally, Per holds an MSc in Business Studies and Economics, majoring in Business Studies, and a BSc in Business Administration and Economics with a focus on International Business Studies, both from Uppsala University in Sweden. This educational background, combined with his extensive professional journey, makes Per Langoe a prominent and influential figure in the financial sector of the healthcare industry.

Our Partners

We are proud to announce that the American Urological Association (AUA), through a rigorous and highly competitive selection process, has selected Global Continence Inc. as “one of the most exciting startups in the field of urology in 2023”. This “Shark Tank” format was moderated by Fox Business News anchor, Charlie Garparino. At the close of the event, Soluu received a top recognition from the panel. Chicago, IL.
Winner for Best Pitch at the Bear Institute Pediatric Accelerator Challenge for Kids (PACK) and Children’s National Medical Center in the Concept Validation Innovation Track. Washington, DC
Winner for Best Pitch at the CTIP and the Alliance for Pediatric Device Innovation (APDI) - a collaboration between two FDA-funded pediatric device consortia. Anaheim, CA
American Academy of Pediatrics and SWPDC grants $25,000.00 award to Global Continence's product Soluu - bedwetting mitigation device
$50,000 grant award by the Pennsylvania Pediatric Medical Device Consortium, Children’s Hospital of Philadelphia

Our Awards